New approaches to the medical treatment of irritable bowel syndrome

被引：2

作者：

Driss Berrada

Katia Canenguez

Tony Lembo

机构：

[1] Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA 02215

来源：

Current Gastroenterology Reports | 2003年 / 5卷 / 4期

关键词：

Irritable Bowel Syndrome; Irritable Bowel Syndrome Patient; Loperamide; Tegaserod; Irritable Bowel Syndrome Symptom;

D O I：

10.1007/s11894-003-0072-0

中图分类号：

学科分类号：

摘要：

Irritable bowel syndrome (IBS) is a common disorder with a worldwide distribution; it is characterized by abdominal pain and discomfort associated with an alteration of bowel function. The treatment approach for IBS depends on the patient's presenting symptoms at the time of diagnosis, and treatment is usually directed toward the predominant symptom. In this review we discuss the current approach to the treatment of IBS. Copyright © 2003 by Current Science Inc.

引用

页码：337 / 342

页数：5

共 48 条

[31]

Jones R.H., Holtmann G., Rodrigo L., Et al., Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients, Aliment. Pharmacol. Ther., 13, pp. 1419-1427, (1999)

[32]

Camilleri M., Mayer E.A., Drossman D.A., Et al., Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist, Aliment. Pharmacol. Ther., 13, pp. 1149-1159, (1999)

[33]

Camilleri M., Chey W.Y., Mayer E.A., Et al., A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome, Arch. Intern. Med., 161, pp. 1733-1740, (2001)

[34]

Cremonini F., Delgado-Aros S., Camilleri M., Efficacy of alosetron in irritable bowel syndrome: A meta-analysis of randomized controlled trials, Neurogastroenterol. Motil., 15, pp. 79-86, (2003)

[35]

Watson M.E., Lacey L., Kong S., Et al., Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome, Am. J. Gastroenterol., 96, pp. 455-459, (2001)

[36]

Jhingran P., Decker C., Watson M., Et al., Alosetron reduces time lost from work in women with diarrhoea-predominant irritable bowel syndrome, Clin. Drug Invest., 21, pp. 843-852, (2001)

[37]

Poynard T., Regimbeau C., Benhamou Y., Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome, Aliment. Pharmacol. Ther., 15, pp. 355-361, (2001)

[38]

Wald A., Psychotropic agents in irritable bowel syndrome, J. Clin. Gastroenterol., 35, SUPPL., (2002)

[39]

Clouse R.E., Prakash C., Anderson R.J., Et al., Antidepressants for functional gastrointestinal symptoms and syndromes: A meta-analysis, Gastroenterology, 120, (2001)

[40]

Clouse R.E., Antidepressants for functional gastrointestinal syndromes, Dig. Dis. Sci., 39, pp. 2352-2363, (1994)

← 1 2 3 4 5 →